Summary
This prediction ended on 03.11.22 with a price of €46.20. The prediction for Roku closed with a convincing performance of -17.36%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Roku | -0.435% | -0.435% | 69.927% | 86.778% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
According to BiotechBee what are the pros and cons of Roku for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Roku diskutieren
Sell mit Kursziel 43,0